Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electroencephalography | 16 | 2018 | 687 | 1.730 |
Why?
|
| Polysomnography | 14 | 2012 | 145 | 1.220 |
Why?
|
| Sleep Stages | 7 | 2018 | 45 | 1.200 |
Why?
|
| Sleep | 14 | 2018 | 423 | 0.850 |
Why?
|
| Wakefulness | 9 | 2012 | 129 | 0.840 |
Why?
|
| Circadian Rhythm | 10 | 2015 | 292 | 0.810 |
Why?
|
| Arousal | 6 | 2008 | 166 | 0.760 |
Why?
|
| Sleep Deprivation | 7 | 2015 | 134 | 0.560 |
Why?
|
| Cerebral Cortex | 3 | 2012 | 552 | 0.510 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2012 | 200 | 0.490 |
Why?
|
| Hydrocortisone | 7 | 2015 | 290 | 0.470 |
Why?
|
| Brain Waves | 1 | 2012 | 32 | 0.450 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 218 | 0.410 |
Why?
|
| Automation | 1 | 2011 | 107 | 0.400 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 101 | 0.390 |
Why?
|
| Trypanosomiasis, African | 5 | 2008 | 6 | 0.330 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 201 | 0.250 |
Why?
|
| Activity Cycles | 2 | 2000 | 19 | 0.240 |
Why?
|
| Heart Rate | 3 | 2020 | 476 | 0.240 |
Why?
|
| Benzhydryl Compounds | 1 | 2003 | 42 | 0.240 |
Why?
|
| Hypothalamus | 2 | 2008 | 77 | 0.230 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2020 | 48 | 0.220 |
Why?
|
| Sleep, REM | 5 | 2012 | 49 | 0.220 |
Why?
|
| Dextroamphetamine | 1 | 2003 | 105 | 0.220 |
Why?
|
| Adrenal Glands | 1 | 2001 | 76 | 0.210 |
Why?
|
| Pituitary Gland | 1 | 2001 | 115 | 0.210 |
Why?
|
| Rest | 1 | 2020 | 43 | 0.200 |
Why?
|
| Prediabetic State | 1 | 2020 | 38 | 0.200 |
Why?
|
| Adult | 24 | 2018 | 24602 | 0.200 |
Why?
|
| Electromyography | 5 | 2011 | 171 | 0.200 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 210 | 0.190 |
Why?
|
| Hypnotics and Sedatives | 2 | 2012 | 126 | 0.180 |
Why?
|
| Electrooculography | 3 | 2011 | 22 | 0.170 |
Why?
|
| Nicotine | 1 | 2018 | 191 | 0.160 |
Why?
|
| Trypanosoma brucei gambiense | 2 | 2008 | 2 | 0.160 |
Why?
|
| Male | 23 | 2020 | 39380 | 0.150 |
Why?
|
| Parathyroid Hormone | 2 | 1997 | 210 | 0.150 |
Why?
|
| Electrocardiography | 4 | 2012 | 466 | 0.150 |
Why?
|
| Artifacts | 3 | 2011 | 237 | 0.150 |
Why?
|
| Humans | 30 | 2020 | 80812 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 70 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 778 | 0.120 |
Why?
|
| Overweight | 1 | 2014 | 113 | 0.120 |
Why?
|
| Holidays | 2 | 2003 | 4 | 0.120 |
Why?
|
| Islam | 2 | 2003 | 33 | 0.110 |
Why?
|
| Delta Rhythm | 3 | 2004 | 19 | 0.110 |
Why?
|
| Fasting | 2 | 2003 | 161 | 0.110 |
Why?
|
| Motivation | 1 | 2014 | 272 | 0.110 |
Why?
|
| Human Growth Hormone | 3 | 2015 | 54 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 323 | 0.090 |
Why?
|
| Female | 13 | 2020 | 42421 | 0.090 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2010 | 199 | 0.090 |
Why?
|
| Narcolepsy | 1 | 2008 | 7 | 0.090 |
Why?
|
| Time Factors | 8 | 2015 | 5087 | 0.090 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2008 | 13 | 0.090 |
Why?
|
| Melatonin | 3 | 2012 | 42 | 0.090 |
Why?
|
| Obesity | 2 | 2014 | 921 | 0.080 |
Why?
|
| Neuropeptides | 1 | 2008 | 112 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2011 | 761 | 0.080 |
Why?
|
| Acetamides | 1 | 2007 | 26 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 377 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 136 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2020 | 213 | 0.070 |
Why?
|
| Chronobiology Disorders | 1 | 2004 | 3 | 0.070 |
Why?
|
| Algorithms | 1 | 2012 | 1776 | 0.060 |
Why?
|
| Adolescent | 5 | 2015 | 8656 | 0.060 |
Why?
|
| Middle Aged | 6 | 2020 | 23934 | 0.060 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2003 | 10 | 0.060 |
Why?
|
| Homeostasis | 2 | 2003 | 393 | 0.060 |
Why?
|
| Darkness | 1 | 2001 | 47 | 0.050 |
Why?
|
| Aldosterone | 1 | 2001 | 65 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 36 | 0.050 |
Why?
|
| Fixation, Ocular | 1 | 2000 | 47 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2015 | 370 | 0.050 |
Why?
|
| Alpha Rhythm | 1 | 2000 | 24 | 0.050 |
Why?
|
| Young Adult | 3 | 2018 | 5713 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2000 | 119 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2000 | 74 | 0.050 |
Why?
|
| Parietal Lobe | 1 | 2000 | 113 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 260 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 1998 | 49 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2014 | 743 | 0.040 |
Why?
|
| Beta Rhythm | 1 | 1998 | 18 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2015 | 851 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 150 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2003 | 348 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1774 | 0.040 |
Why?
|
| Autonomic Nervous System | 2 | 2010 | 55 | 0.040 |
Why?
|
| Insulin | 2 | 2015 | 1133 | 0.040 |
Why?
|
| Thyrotropin | 1 | 1998 | 272 | 0.040 |
Why?
|
| Physical Endurance | 1 | 1997 | 9 | 0.040 |
Why?
|
| Parathyroid Glands | 1 | 1997 | 72 | 0.040 |
Why?
|
| Cognition | 1 | 2000 | 501 | 0.040 |
Why?
|
| Phosphates | 1 | 1996 | 149 | 0.040 |
Why?
|
| Child | 2 | 2005 | 6538 | 0.030 |
Why?
|
| Calcium | 2 | 1997 | 1117 | 0.030 |
Why?
|
| Food, Organic | 1 | 2014 | 3 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 164 | 0.030 |
Why?
|
| Appetite | 1 | 2014 | 26 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 332 | 0.030 |
Why?
|
| Food Preferences | 1 | 2014 | 23 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2014 | 30 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 133 | 0.030 |
Why?
|
| Actigraphy | 1 | 2014 | 47 | 0.030 |
Why?
|
| Vegetables | 1 | 2014 | 45 | 0.030 |
Why?
|
| Energy Intake | 1 | 2014 | 96 | 0.030 |
Why?
|
| Fruit | 1 | 2014 | 73 | 0.030 |
Why?
|
| Exercise | 1 | 1997 | 287 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 154 | 0.030 |
Why?
|
| Lighting | 1 | 2012 | 30 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 45 | 0.030 |
Why?
|
| Reference Values | 2 | 2008 | 659 | 0.030 |
Why?
|
| Biomarkers | 2 | 2015 | 1600 | 0.030 |
Why?
|
| Body Temperature | 2 | 2003 | 119 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 690 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 1997 | 657 | 0.030 |
Why?
|
| Renin | 2 | 2001 | 76 | 0.030 |
Why?
|
| Hormones | 1 | 2010 | 135 | 0.020 |
Why?
|
| Critical Illness | 1 | 2012 | 266 | 0.020 |
Why?
|
| Hematocrit | 2 | 2001 | 67 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2012 | 347 | 0.020 |
Why?
|
| Angola | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cataplexy | 1 | 2008 | 1 | 0.020 |
Why?
|
| Orexins | 1 | 2008 | 8 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2008 | 155 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 113 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 679 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2007 | 126 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2008 | 231 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 295 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2004 | 2284 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 299 | 0.020 |
Why?
|
| Melarsoprol | 1 | 2005 | 1 | 0.020 |
Why?
|
| Trypanocidal Agents | 1 | 2005 | 2 | 0.020 |
Why?
|
| Oscillometry | 1 | 2004 | 25 | 0.020 |
Why?
|
| Thorax | 1 | 2004 | 56 | 0.020 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2004 | 4 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5122 | 0.020 |
Why?
|
| Financing, Government | 1 | 2003 | 22 | 0.020 |
Why?
|
| Rectum | 1 | 2003 | 152 | 0.010 |
Why?
|
| Movement | 1 | 2004 | 284 | 0.010 |
Why?
|
| Facial Muscles | 1 | 2001 | 24 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2008 | 7531 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2003 | 119 | 0.010 |
Why?
|
| Animals | 3 | 2008 | 25628 | 0.010 |
Why?
|
| Disease Outbreaks | 1 | 2003 | 161 | 0.010 |
Why?
|
| Diuresis | 1 | 2001 | 29 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 426 | 0.010 |
Why?
|
| Prolactin | 1 | 2001 | 88 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2001 | 131 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1190 | 0.010 |
Why?
|
| Affect | 1 | 2003 | 378 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3528 | 0.010 |
Why?
|
| Potassium | 1 | 2001 | 277 | 0.010 |
Why?
|
| Sodium | 1 | 2001 | 337 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 2001 | 107 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 895 | 0.010 |
Why?
|
| Time | 1 | 1998 | 74 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 1998 | 61 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1998 | 78 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3904 | 0.010 |
Why?
|
| Hyperparathyroidism | 1 | 1997 | 67 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 32 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 267 | 0.010 |
Why?
|
| Phosphorus | 1 | 1997 | 116 | 0.010 |
Why?
|
| Veins | 1 | 1997 | 95 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 489 | 0.010 |
Why?
|
| Bone Density | 1 | 1997 | 202 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 17464 | 0.010 |
Why?
|
| Kidney | 1 | 2001 | 1171 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1997 | 287 | 0.010 |
Why?
|